GLP-1 coverage in Manitoba

Manitoba Pharmacare uses an income-based deductible model: your household's adjusted family net income sets an annual deductible you pay before Pharmacare starts contributing toward eligible prescriptions, including GLP-1 medications like Ozempic when prescribed for type 2 diabetes and approved under the province's Exception Drug Status process for restricted-listing drugs.

Because the deductible is calculated once per Pharmacare year and applies across your household's combined eligible drug costs, whether a specific GLP-1 prescription is effectively 'covered' depends heavily on where your household sits relative to that threshold, not just on whether the drug appears on the formulary.

Manitoba's Exception Drug Status approvals for semaglutide and tirzepatide products are tied to a type 2 diabetes diagnosis and related clinical criteria, not to body weight. A prescription for Wegovy, Saxenda, or an off-label weight-loss use of a diabetes-indicated GLP-1 falls outside what Pharmacare will apply toward your deductible or reimburse.

This matches every other public drug plan in Canada: none currently pays for a GLP-1 prescribed specifically for weight management. Exception Drug Status criteria are reviewed periodically, so confirm current rules directly with Manitoba Pharmacare rather than relying on outdated information.

For Manitobans paying out of pocket, either because a prescription is for weight loss or because they haven't yet met their Pharmacare deductible, Costco Pharmacy is generally the least expensive dispensing option nationally, and no membership is required to use the pharmacy counter. Generic semaglutide, launched by Apotex and Dr. Reddy's in May 2026, runs roughly $88 to $99/mo nationally, though Manitoba-specific Costco pricing hasn't been independently verified here.

Brand-name products cost considerably more at retail: Ozempic $250-$310/mo, Wegovy $400-$570/mo, Mounjaro $280-$550/mo, and Zepbound $435-$550/mo. About 31% of employer private drug plans now offer some GLP-1 weight-loss coverage, and manufacturer savings cards (Ozempic savings card, WegovyCare, myMounjaro, LillyConnect) can lower brand costs, mostly for those who already have private insurance. Compounded GLP-1 products are not a legal option in Canada.